Eleven US IPOs raised a combined $708 million in November, well below the month's historical 10-year average (16 IPOs, $4.2B). Deal flow was led by three sizable issuers, and remaining activity came from smaller companies, all of which raised $33 million or less...read more
One small IPO and one SPAC priced this past week as markets slowed around the Thanksgiving holiday. Skincare company Elevai Labs (ELAB) priced at the low end to raise $6 million at a $69 million market cap. Small and highly unprofitable, the...read more
Elevai Labs, which makes physician-dispensed skincare products, raised $6 million by offering 1.5 million shares at $4, the low end of the range of $4 to $6. Elevai Labs is a physician-dispensed skincare company, which refers to a sales channel where cosmetics...read more
The third quarter wrapped up with four IPOs and eight pipeline additions. Oncology biotech Adlai Nortye (ANL) raised $58 million at an $849 million market cap. The company originally planned to raise $72 million in August but never priced; it...read more
Renaissance Capital's November IPO Market Update
Eleven US IPOs raised a combined $708 million in November, well below the month's historical 10-year average (16 IPOs, $4.2B). Deal flow was led by three sizable issuers, and remaining activity came from smaller companies, all of which raised $33 million or less...read more
US IPO Weekly Recap: IPO market sees a little activity in the short holiday week
One small IPO and one SPAC priced this past week as markets slowed around the Thanksgiving holiday. Skincare company Elevai Labs (ELAB) priced at the low end to raise $6 million at a $69 million market cap. Small and highly unprofitable, the...read more
Skincare company Elevai Labs prices IPO at $4, the low end of the range
Elevai Labs, which makes physician-dispensed skincare products, raised $6 million by offering 1.5 million shares at $4, the low end of the range of $4 to $6. Elevai Labs is a physician-dispensed skincare company, which refers to a sales channel where cosmetics...read more
US IPO Weekly Recap: Holdover Adlai Nortye leads 4 IPO week as more small deals enter the pipeline
The third quarter wrapped up with four IPOs and eight pipeline additions. Oncology biotech Adlai Nortye (ANL) raised $58 million at an $849 million market cap. The company originally planned to raise $72 million in August but never priced; it...read more